The largest database of trusted experimental protocols

4 protocols using pb0245

1

Immunohistochemical Analysis of Angiogenic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin-embedded tissue sections (4 μm) were subjected to antigen retrieval, incubation with anti-CD31 (ab28364, abcam), anti-VEGF-A (BA0407, Boster), anti-HIF-1A (PB0245, Boster), anti-CD34 (BA0532, Boster), or anti-TSP1 (ab93653, abcam) antibodies, followed by incubation with a peroxidase-conjugated goat anti-rabbit IgG (KIT-9706, Maixin-Bio) secondary antibody. Samples were developed with DAB or AEC and counterstained with Mayor's hematoxylin (AR0005, Boster). Image Pro Plus 6.0 software was used for quantitative analysis.
+ Open protocol
+ Expand
2

Western Blot Analysis of Apoptosis Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed using primary antibodies against RIP1 (1:1,000, 17519-1-AP; Proteintech, Rosemont, IL, USA), RIP3 (1:1,000, 17563-1-AP; Proteintech), HIF-1α (1:1,000, PB0245; BOSTER Biological Technology, Pleasanton, CA, USA), TRPC6 (1:400, BA3394; BOSTER Biological Technology), PARP1 (1:1,000, PB0343; BOSTER Biological Technology), Sirtuin-2 (1:1,000; PB0174; BOSTER Biological Technology), and GAPDH (1:10,000, RC-5G5; KangChen Bio-tech, Shanghai, China), followed by incubation with a horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG) antibody (1:20,000, BA1054; BOSTER Biological Technology) for 1 h at room temperature. The signals were detected by enhanced chemiluminescence (Pierce, Rockford, IL, USA).
+ Open protocol
+ Expand
3

Immunofluorescence Staining of HK-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunofluorescence staining, cultured HK-2 cells were fixed with 4% buffered paraformaldehyde in PBS and then washed with PBS for 5 min. Next, the cells were incubated overnight at 4°C with primary antibodies against RIP3 (17563-1-AP; Proteintech), HIF-1α (PB0245; BOSTER Biological Technology), TRPC6 (BA3394; BOSTER Biological Technology), PARP1 (PB0343; BOSTER Biological Technology), and Sirtuin-2 (PB0174; BOSTER Biological Technology), followed by incubation with a FITC-labeled anti-goat secondary antibody (Beyotime Institute of Biotechnology). The cell nuclei were stained with DAPI (Beyotime, Shanghai, China) for 20 min at room temperature. Immunofluorescence was examined under an inverted fluorescence microscope (Olympus Corporation, Japan).
+ Open protocol
+ Expand
4

OSCC Tissue Immunohistochemistry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the OSCC specimens were obtained from the 73 patients. Ten corresponding normal tissue samples, which came from the 73 patients' normal oesophagus (5 cm away from ESCC) randomly, were used as controls. The tissue specimens were fixed in 10% neutral buffered formalin and processed routinely. Hypoxiainducible factor 1α and VEGF were detected by the streptavidin-peroxidase (SP) method using the same paraffin-embedded tissue samples, which were cut into 4-mm-thick slices. The primary antibody was applied using rabbit anti-human monoclonal HIF-1α antibodies (1:100, Catalogue #PB0245, Boster Biological Technology, Wuhan, P.R. China) or rabbit anti-human monoclonal VEGF antibodies (1:100, Catalogue #BA0407, Boster Biological Technology, Wuhan, P.R. China). A secondary antibody was applied using Goat Anti-Rabbit IgG Antibody (1:100, Catalogue #BA1003, Boster Biological Technology, Wuhan, P.R. China). When intensive positive staining of HIF-1α or VEGF was observed in more than 10% of the tumour cells, the case was considered HIF-1αpositive or VEGF-positive. These evaluation criteria have been described in previous reports [8, 9, 10, 11] .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!